tadalafil has been researched along with scopolamine hydrobromide in 4 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | tadalafil (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gong, Q; Li, J; Li, X; Ling, D; Mao, F; Ni, W; Wang, H; Wang, M; Zhang, H; Zhang, J; Zheng, X | 1 |
| Amelinia, F; Belaran, M; Fanoudi, S; Mirzaei, H; Pourheidar, S; Tabrizian, K | 1 |
| Otari, KV; Patil, RJ; Upasani, CD | 1 |
1 review(s) available for tadalafil and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for tadalafil and scopolamine hydrobromide
| Article | Year |
|---|---|
Novel Tadalafil Derivatives Ameliorates Scopolamine-Induced Cognitive Impairment in Mice via Inhibition of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5).
Topics: Acetylcholinesterase; Animals; Brain; Cholinesterase Inhibitors; Cognitive Dysfunction; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Mice, Inbred ICR; Molecular Structure; Phosphodiesterase 5 Inhibitors; Random Allocation; Scopolamine; Tadalafil | 2018 |
Tadalafil Reversed H-89 - and Scopolamine - Induced Spatial Learning Impairments in Male Rats.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Cyclic GMP; Hippocampus; Isoquinolines; Male; Maze Learning; Memory; Rats; Rats, Wistar; Scopolamine; Signal Transduction; Spatial Learning; Sulfonamides; Tadalafil | 2021 |
Improvement of cognitive dysfunction by a novel phosphodiesterase type 5 inhibitor, Tadalafil.
Topics: Cognitive Dysfunction; Cyclic GMP; Humans; Memory Disorders; NG-Nitroarginine Methyl Ester; Phosphodiesterase 5 Inhibitors; Scopolamine; Tadalafil | 2023 |